Advertisement
New Zealand markets closed
  • NZX 50

    11,755.17
    +8.59 (+0.07%)
     
  • NZD/USD

    0.6024
    -0.0010 (-0.17%)
     
  • NZD/EUR

    0.5588
    -0.0006 (-0.11%)
     
  • ALL ORDS

    8,022.70
    +28.50 (+0.36%)
     
  • ASX 200

    7,749.00
    +27.40 (+0.35%)
     
  • OIL

    78.37
    -0.89 (-1.12%)
     
  • GOLD

    2,372.50
    +32.20 (+1.38%)
     
  • NASDAQ

    18,164.38
    +50.92 (+0.28%)
     
  • FTSE

    8,433.76
    +52.41 (+0.63%)
     
  • Dow Jones

    39,524.99
    +137.23 (+0.35%)
     
  • DAX

    18,772.85
    +86.25 (+0.46%)
     
  • Hang Seng

    18,963.68
    +425.87 (+2.30%)
     
  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     
  • NZD/JPY

    93.8140
    +0.0460 (+0.05%)
     

Adaptive Biotechnologies Corporation (ADPT) Q1 2022 Earnings Call Transcript

Adaptive Biotechnologies Corporation (ADPT) Q1 2022 Earnings Call Transcript

Ladies and gentlemen, thank you for standing by, and welcome to the Adaptive Biotechnologies first quarter 2022 financial results conference call. In addition, Harlan Robins, Adaptive chief scientific officer and co-founder; Nitin Sood, head of our MRG business; and Sharon Benzeno, head of the immune medicine business, will be available for Q&A. With that, I'll turn the call to Chad Robins.